Amicus Therapeutics on Patient Centricity in the Temp-Controlled Supply Chains

Amicus Therapeutics on Patient Centricity in the Temp-Controlled Supply Chains

We sat down with John Crowley, Chairman and CEO of Amicus Therapeutics this fall to discuss 

  • The macro pressures affecting the cold chain industry that will have a direct impact over the next 12 months
  • What keeps him up at night about cold chain and how he plans on fixing it
  • How is the industry going to achieve the optimal equilibrium between patient-centricity, operational and cost efficiency?
  • His top priorities over the next 12 months

Please note: That all fields marked with an asterisk (*) are required.